Compile Data Set for Download or QSAR
Report error Found 90 Enz. Inhib. hit(s) with all data for entry = 12553
TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708742BDBM708742(4-(5-(4-((3-hydroxypiperidin-1- yl)methyl)phenyl)-...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708806BDBM708806(1-(4-(3-(1H-indol-5-yl)-1H- pyrrolo[2,3-b]pyridin-...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708803BDBM708803(1-(1-(4-(3-(6-methoxypyridin-3- yl)-1H-pyrrolo[2,3...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708740BDBM708740(1-(4-(3-(3,5-difluorophenyl)- 1H-pyrrolo[2,3-b]pyr...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708804BDBM708804(1-(4-(3-(1H-indol-5-yl)-1H- pyrrolo[2,3-b]pyridin-...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708737BDBM708737(1-(4-(3-(3- (difluoromethyl)phenyl)-1H- pyrrolo[2,...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708813BDBM708813(1-(4-(3-(4-(2-hydroxypropan-2- yl)phenyl)-1H-pyrro...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708814BDBM708814(1-(4-(3-(2-fluoropyridin-4-yl)-2- (furan-3-yl)-1H-...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708811BDBM708811(1-(4-(3-(4- (hydroxymethyl)phenyl)-1H- pyrrolo[2,3...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708812BDBM708812(1-(4-(3-(2-methyloxazolo[5,4- b]pyridin-6-yl)-1H-p...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708745BDBM708745(1-(4-(3-(4- ((dimethylamino)methyl)phenyl)- 1H-pyr...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708746BDBM708746(5-(5-(4-((3-hydroxypiperidin-1- yl)methyl)phenyl)-...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708743BDBM708743(3-(5-(4-((3-hydroxypiperidin-1- yl)methyl)phenyl)-...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708807BDBM708807(3-(1H-indol-5-yl)-5-(4- (piperidin-1-ylmethyl)phen...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708744BDBM708744(1-(4-(3-(4-hydroxyphenyl)-1H- pyrrolo[2,3-b]pyridi...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708808BDBM708808(1-(4-(3-(1,2,3,4- tetrahydroisoquinolin-6-yl)-1H- ...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708789BDBM708789(1-(4-(3-(2- (difluoromethyl)pyridin-4-yl)-2- ethyl...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708787BDBM708787(1-(4-(2-ethyl-3-(6- methoxypyridin-3-yl)-1H- pyrro...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708788BDBM708788(1-(4-(2-ethyl-3-(2- fluoropyridin-4-yl)-1H- pyrrol...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708785BDBM708785(1-(4-(2-ethyl-3-(3- fluorophenyl)-1H-pyrrolo[2,3- ...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708786BDBM708786(1-(4-(3-(6- (difluoromethyl)pyridin-3-yl)-2- ethyl...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708784BDBM708784(1-(4-(2-chloro-3-(6- methoxypyridin-3-yl)-1H- pyrr...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708795BDBM708795(1-(4-(2-(ethoxymethyl)-3-(3- fluorophenyl)-1H-pyrr...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708732BDBM708732(1-(4-(3-(3-fluorophenyl)-1H- pyrrolo[2,3-b]pyridin...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708793BDBM708793(1-(4-(3-(2-fluoropyridin-4-yl)-2- (methoxymethyl)-...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708730BDBM708730(1-(4-(3-(m-tolyl)-1H- pyrrolo[2,3-b]pyridin-5- yl)...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708794BDBM708794(1-(4-(3-(2- (difluoromethyl)pyridin-4-yl)-2- (meth...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708791BDBM708791(1-(4-(3-(3-fluorophenyl)-2- (methoxymethyl)-1H- py...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708773BDBM708773(3-(1H-indol-5-yl)-5-(4-((4- methoxypiperidin-1- yl...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708774BDBM708774(3-(1H-indol-5-yl)-5-(4-((3- methoxyazetidin-1- yl)...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708772BDBM708772(1-(4-(3-(1H-indol-5-yl)-1H- pyrrolo[2,3-b]pyridin-...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708781BDBM708781(2-hydroxy-5-(5-(4-((3- hydroxypiperidin-1- yl)meth...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708779BDBM708779(1-(4-(3-(2- methylbenzo[d]oxazol-5-yl)- 1H-pyrrolo...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708780BDBM708780(1-(4-(3-(7- fluorobenzo[d]oxazol-5-yl)-1H- pyrrolo...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708777BDBM708777(1-(4-(3-(1H-indazol-4-yl)-1H- pyrrolo[2,3-b]pyridi...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708778BDBM708778(1-(4-(3-(benzo[d]oxazol-5-yl)- 1H-pyrrolo[2,3-b]py...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708775BDBM708775(1-(4-(1H,1'H-[3,5'- bipyrrolo[2,3-b]pyridin]-5- yl...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708776BDBM708776(1-(4-(3-(1H-indazol-6-yl)-1H- pyrrolo[2,3-b]pyridi...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708753BDBM708753(1-(4-(3-(6-methoxypyridin-3- yl)-1H-pyrrolo[2,3-b]...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708754BDBM708754(1-(4-(3-(6-methoxypyridin-3- yl)-1H-pyrrolo[2,3-b]...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708818BDBM708818(1-(4-(2-(cyclopropylmethyl)-3- (3-fluorophenyl)-1H...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708751BDBM708751(1-(4-(3-(6- (difluoromethyl)pyridin-3-yl)- 1H-pyrr...)
Affinity DataIC50: 51nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708739BDBM708739(1-(4-(3-(3- (trifluoromethyl)phenyl)-1H- pyrrolo[2...)
Affinity DataIC50: 100nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708735BDBM708735(1-(4-(3-(4-chlorophenyl)-1H- pyrrolo[2,3-b]pyridin...)
Affinity DataIC50: 100nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708799BDBM708799(1-(4-(3-(6-methoxypyridin-3- yl)-1H-pyrrolo[2,3-b]...)
Affinity DataIC50: 100nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708736BDBM708736(1-(4-(3-(3-chlorophenyl)-1H- pyrrolo[2,3-b]pyridin...)
Affinity DataIC50: 100nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708749BDBM708749(1-(4-(3-(6-fluoropyridin-3-yl)- 1H-pyrrolo[2,3-b]p...)
Affinity DataIC50: 100nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708750BDBM708750(1-(4-(3-(5-fluoropyridin-3-yl)- 1H-pyrrolo[2,3-b]p...)
Affinity DataIC50: 100nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708747BDBM708747(5-(5-(4-((3-hydroxypiperidin-1- yl)methyl)phenyl)-...)
Affinity DataIC50: 100nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase receptor TYRO3(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708748BDBM708748(1-(4-(3-(6-methylpyridin-3-yl)- 1H-pyrrolo[2,3-b]p...)
Affinity DataIC50: 100nMAssay Description:Poly(Glu, Tyr) sodium salt (Glu:Tyr (4:1), quality level 200, molecular weight 5,000-20,000, obtained from Sigma Aldrich, catalogue #P7244, assay con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

Displayed 1 to 50 (of 90 total ) | Next | Last >>
Jump to: